歐洲功能基因組市場：分析與預測（2023-2033）

2023年歐洲功能基因組市場規模為30.1億美元。

預計2033年市場規模將達106.9億美元，2023-2033年預測期間複合年成長率為13.52%。功能基因組學市場有望成長，主要是由於應用不斷擴大，特別是在標靶治療和精準醫學領域。

由於基因組研究的進步和對個人化醫療的需求不斷增加，歐洲功能基因組市場正在經歷顯著成長。功能基因組學是研究基因如何相互作用以及與環境相互作用以了解生物功能的學科。歐洲在生物技術和生命科學領域的強大實力以及在研發方面的大量投資促使了旨在闡明該地區疾病機制和開發標靶治療的基因組研究激增。此外，學術機構、生物技術公司和政府機構之間的合作正在促進創新並支持市場擴張。此外，高通量定序和基因編輯技術的日益採用也進一步推動了功能基因組學市場的發展。隨著歐洲在基因組學研究方面繼續處於領先地位，功能基因組學市場正在持續成長，為醫療保健和生物技術的進步提供了充滿希望的機會。

該報告考察了歐洲功能基因組學市場，提供了市場概述、各國趨勢以及進入市場的公司概況。

目錄

執行摘要

第1章 市場

• 產品定義
• 涵蓋與排除標準
• 市場範圍
• 調查方法

第2章 市場概況

• 功能基因體學工作流程分析
• 未來性
• 功能基因體學的影響
  • 基因治療
  • 藥物研發發現與開發
  • 基因表現
  • 單細胞分析

第3章 區域

• 概述
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他地區

第4章 公司簡介

• F. Hoffmann-La Roche Ltd
• Merck KGaA
• QIAGEN

The Europe Functional Genomics Market Expected to Reach $10.69 Billion by 2033

Introduction to Europe Functional Genomics Market

In 2023, the Europe functional genomics market was valued at $3.01 billion, and it is expected to reach $10.69 billion by 2033, growing at a CAGR of 13.52% during the forecast period 2023-2033. The functional genomics market is poised for growth, primarily propelled by its expanding applications, particularly in the realms of targeted therapy and precision medicine.

Market Introduction

The functional genomics market in Europe is experiencing notable growth driven by advancements in genomic research and rising demand for personalized medicine. Functional genomics involves studying how genes interact with each other and the environment to understand biological functions. With Europe's strong presence in biotechnology and life sciences, coupled with significant investments in research and development, the region is witnessing a surge in genomic studies aimed at unraveling disease mechanisms and developing targeted therapies. Moreover, collaborations between academic institutions, biotech companies, and government agencies are fostering innovation and driving market expansion. Additionally, increasing adoption of high-throughput sequencing and gene editing technologies further propels the functional genomics market. As Europe continues to lead in genomic research, the functional genomics market is poised for continued growth, offering promising opportunities for advancements in healthcare and biotechnology.

Market Segmentation:

Segmentation 1: by Country

• Germany
• France
• U.K.
• Italy
• Spain
• Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The report considers functional genomics kits and assays-based companies. The industry is seeing constant development and product launches with new and innovative upgrades. Additionally, new discoveries of more efficient instruments and tools of functional genomics are increasing researchers' trust in functional genomics.

Growth/Marketing Strategy: The key components in Europe functional genomics are the kits and assays along with the instruments for sample analysis. The advancements in the overall functional genomics ecosystem are influencing the growth of this market.

Competitive Strategy: The key players in the Europe functional genomics market have been analyzed and profiled in the study, consisting of most product-based companies. Moreover, a detailed competitive benchmarking of the players operating in the Europe functional genomics market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

• F. Hoffmann-La Roche Ltd
• Merck KGaA
• QIAGEN

Table of Contents

Executive Summary

1 Markets

• 1.1 Product Definition
• 1.2 Inclusion and Exclusion Criteria
• 1.3 Market Scope
  • 1.3.1 Scope of the Study
  • 1.3.2 Key Questions Answered in the Report
• 1.4 Research Methodology
  • 1.4.1 Functional Genomics Market: Research Methodology
  • 1.4.2 Data Sources
  • 1.4.3 Market Estimation Model
  • 1.4.4 Criteria for Company Profiling

2 Market Overview

• 2.1 Functional Genomics Workflow Analysis
• 2.2 Future Potential
• 2.3 Impact of Functional Genomics
  • 2.3.1 Gene Therapy
  • 2.3.2 Drug Discovery and Development
  • 2.3.3 Gene Expression
  • 2.3.4 Single-Cell Analysis

3 Region

• 3.1 Overview
• 3.2 Europe
  • 3.2.1 Germany
  • 3.2.2 France
  • 3.2.3 U.K.
  • 3.2.4 Italy
  • 3.2.5 Spain
  • 3.2.6 Rest-of-Europe

4 Company Profiles

• 4.1 Overview
• 4.2 F. Hoffmann-La Roche Ltd
  • 4.2.1 Company Overview
  • 4.2.2 Role of F. Hoffmann-La Roche Ltd in the Functional Genomics Market
  • 4.2.3 Financials
  • 4.2.4 Key Insights about the Financial Health of the Company
  • 4.2.5 Recent Developments
  • 4.2.6 Analyst Perspective
• 4.3 Merck KGaA
  • 4.3.1 Company Overview
  • 4.3.2 Role of Merck KGaA in the Functional Genomics Market
  • 4.3.3 Financials
  • 4.3.4 Key Insights about the Financial Health of the Company
  • 4.3.5 Analyst Perspective
• 4.4 QIAGEN
  • 4.4.1 Company Overview
  • 4.4.2 Role of QIAGEN in the Functional Genomics Market
  • 4.4.3 Financials
  • 4.4.4 Key Insights about the Financial Health of the Company
  • 4.4.5 Recent Developments
  • 4.4.6 Analyst Perspective

List of Figures

• Figure 1: Europe Functional Genomics Market, $Billion, 2023 and 2033
• Figure 2: Biological Features of Functional Genomics Approaches
• Figure 3: Share of Functional Genomics Market (by Region), 2022
• Figure 4: Functional Genomics Market: Research Methodology
• Figure 5: Primary Research Methodology
• Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 7: Top-Down Approach (Segment-Wise Analysis)
• Figure 8: Epigenomics Workflow
• Figure 9: Transcriptomics Workflow
• Figure 10: Proteomics Workflow
• Figure 11: Metabolomics Workflow
• Figure 12: Functional Genomics Market Snapshot (by Region)
• Figure 13: Functional Genomics Market (by Region), $Billion, 2023-2033
• Figure 14: Europe Functional Genomics Market, $Billion, 2022-2033
• Figure 15: Europe Functional Genomics Market (by Country), $Billion, 2022-2033
• Figure 16: Germany Functional Genomics Market, $Billion, 2022-2033
• Figure 17: France Functional Genomics Market, $Billion, 2022-2033
• Figure 18: U.K. Functional Genomics Market, $Billion, 2022-2033
• Figure 19: Italy Functional Genomics Market, $Billion, 2022-2033
• Figure 20: Spain Functional Genomics Market, $Billion, 2022-2033
• Figure 21: Rest-of-Europe Functional Genomics Market, $Billion, 2022-2033
• Figure 22: Functional Genomics Market, Total Number of Key Companies Profiled
• Figure 23: F. Hoffmann-La Roche Ltd: Product Portfolio
• Figure 24: F. Hoffmann-La Roche Ltd: Overall Financials, 2020-2022
• Figure 25: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2020-2022
• Figure 26: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2020-2022
• Figure 27: Merck KGaA: Product Portfolio
• Figure 28: Merck KGaA: Overall Financials, $Million, 2020-2022
• Figure 29: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
• Figure 30: Merck KGaA: Revenue (by Region), $Million, 2020-2022
• Figure 31: Merck KGaA: R&D Expenditure, $Million, 2020-2022
• Figure 32: QIAGEN.: Product Portfolio
• Figure 33: QIAGEN: Overall Financials, $Million, 2019-2021
• Figure 34: QIAGEN: Revenue (by Segment), $Million, 2019-2021
• Figure 35: QIAGEN: Revenue (by Region), $Million, 2019-2021
• Figure 36: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021

List of Tables

• Table 1: Europe Functional Genomics Market: Impact Analysis
• Table 2: Technological Trends in Functional Genomics Market
• Table 3: Europe: Market Dynamics